A STUDY ON THE ROLE OF THE RB1 GENE AS A PROGNOSTIC FACTOR IN UNTREATED PATIENTS WITH B-CHRONIC LYMPHOCYTIC LEUKEMIA
Chronic lymphocytic leukemia (CLL) is one of the most common leukemias in adults. After 2000, the FDA approved drugs for its treatment with mechanisms of action different from those of the then-known cytostatics. This new therapeutic approach, employing targeted therapy, is based on a better underst...
Saved in:
Main Authors: | Vanya Slavcheva (Author), Svetlana Angelova (Author), Georgi Balatzenko (Author), Tzvetan Lukanov (Author), Pencho Tonchev (Author) |
---|---|
Format: | Book |
Published: |
Peytchinski Publishing,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLINICAL STUDY OF GENE EXPRESSION PROFILE AND SOME OF THE MOST COMMON CHROMOSOMAL ABERRATIONS IN UNTREATED B-CHRONIC LYMPHOCYTIC LEUKAEMIA PATIENTS
by: Vanya Slavcheva
Published: (2020) -
Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia
by: Joanna Gora-Tybor, et al.
Published: (2003) -
Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia
by: Xiaoya Yun, et al.
Published: (2020) -
Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA
by: Sikander Ailawadhi, et al.
Published: (2024) -
UNUSUAL CLINICAL PRESENTATION OF RELAPSE IN PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.
by: Vanya Slavcheva, et al.
Published: (2015)